Physician profile
Timothy Obrien
NPI 1922008374
$2,023.81
in general payments reported to CMS, 2019-2025
13 companies · $293 in 2025
The $293 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $70.08 · 2021: $353 · 2022: $255 · 2023: $258 · 2024: $343 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $894.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $641.12 | 2019-2025 | Evos Mini, Maverick, Trigen |
| Zimmer Biomet Holdings, INC. | $355.23 | 2019-2025 | Comprehensive Shoulder System, G7 |
| Vericel Corporation | $295.60 | 2020-2025 | Maci |
| Stryker Corporation | $291.03 | 2019-2024 | Tornier Perform Reversed Augmented Glenoid, Simpliciti, Blueprint Patient Specific Instrumentation |
| Sioux Surgical INC | $233.03 | 2020-2024 | |
| Heron Therapeutics, INC. | $38.29 | 2025 | Zynrelef |
| Avanos Medical | $37.61 | 2019-2021 | |
| Xiros INC | $28.50 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $28.29 | 2024 | Exparel, Zilretta, Iovera |
| Depuy Synthes Sales INC. | $24.42 | 2025 | Monovisc, Orthovisc |
| Baxter Healthcare | $19.20 | 2021 | |
| Solventum Corporation | $17.63 | 2025 | Prevena, Promogran Prisma, Activ.A.C. |
| Bioventus LLC | $13.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Obrien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.